Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014302862> ?p ?o ?g. }
- W2014302862 endingPage "152" @default.
- W2014302862 startingPage "140" @default.
- W2014302862 abstract "Renin-angiotensin-aldosterone system (RAAS) blockade improves outcome in cardiovascular disease (CVD) and chronic kidney disease (CKD), but the residual risk during monotherapy RAAS blockade remains very high. This review discusses the place of dual RAAS blockade in improving these outcomes.The combination of angiotensin-converting enzyme inhibitor (ACEI) with angiotensin II type 1 receptor blocker (ARB) generally had a better antihypertensive and antiproteinuric effect than monotherapy in many studies, but is also associated with more adverse effects. Unfortunately, the effect on hard renal and cardiovascular endpoints is not unequivocal. The combination of ACEI (or ARB) with aldosterone blockade has long-term benefits in heart failure, and an added effect on proteinuria in CKD, but data on hard renal endpoints are lacking. Dual blockade including renin inhibition has added antiproteinuric effects, but studies to gather long-term data are still under way. Available strategies to optimize the effect of monotherapy RAAS blockade include dose titration and correction of volume excess. Whether dual blockade has better efficacy and/or fewer adverse effects than optimized monotherapy has not been investigated.Several options are available to increase the effect of monotherapy RAAS blockade. For proteinuric CKD, these can be combined in a stepwise approach aimed at maximal proteinuria reduction; this includes dual blockade for patients with persistent proteinuria during optimized monotherapy RAAS blockade. Long-term randomized studies, however, are needed to support the benefits of dual blockade for long-term renal and cardiovascular outcome in CKD." @default.
- W2014302862 created "2016-06-24" @default.
- W2014302862 creator A5000097859 @default.
- W2014302862 creator A5009761624 @default.
- W2014302862 creator A5065785268 @default.
- W2014302862 date "2010-03-01" @default.
- W2014302862 modified "2023-09-23" @default.
- W2014302862 title "Dual blockade of the renin–angiotensin–aldosterone system in cardiac and renal disease" @default.
- W2014302862 cites W180946569 @default.
- W2014302862 cites W1892387683 @default.
- W2014302862 cites W1963930171 @default.
- W2014302862 cites W1964833810 @default.
- W2014302862 cites W1968443062 @default.
- W2014302862 cites W1971443181 @default.
- W2014302862 cites W1975603373 @default.
- W2014302862 cites W1978998472 @default.
- W2014302862 cites W1985025184 @default.
- W2014302862 cites W1994079702 @default.
- W2014302862 cites W1995262353 @default.
- W2014302862 cites W1995311541 @default.
- W2014302862 cites W1996191860 @default.
- W2014302862 cites W1997832120 @default.
- W2014302862 cites W1998038903 @default.
- W2014302862 cites W2002616791 @default.
- W2014302862 cites W2002839070 @default.
- W2014302862 cites W2006427666 @default.
- W2014302862 cites W2007204386 @default.
- W2014302862 cites W2010775169 @default.
- W2014302862 cites W2010799694 @default.
- W2014302862 cites W2010912810 @default.
- W2014302862 cites W2018629716 @default.
- W2014302862 cites W2019019126 @default.
- W2014302862 cites W2019639026 @default.
- W2014302862 cites W2020860227 @default.
- W2014302862 cites W2022266546 @default.
- W2014302862 cites W2022724650 @default.
- W2014302862 cites W2022846000 @default.
- W2014302862 cites W2023727063 @default.
- W2014302862 cites W2030408237 @default.
- W2014302862 cites W2034146561 @default.
- W2014302862 cites W2037414643 @default.
- W2014302862 cites W2038432404 @default.
- W2014302862 cites W2038880847 @default.
- W2014302862 cites W2039883351 @default.
- W2014302862 cites W2041864236 @default.
- W2014302862 cites W2044773944 @default.
- W2014302862 cites W2044844096 @default.
- W2014302862 cites W2050071967 @default.
- W2014302862 cites W2052653818 @default.
- W2014302862 cites W2056893352 @default.
- W2014302862 cites W2056976690 @default.
- W2014302862 cites W2060371217 @default.
- W2014302862 cites W2061018844 @default.
- W2014302862 cites W2064025400 @default.
- W2014302862 cites W2064532153 @default.
- W2014302862 cites W2065749779 @default.
- W2014302862 cites W2067519483 @default.
- W2014302862 cites W2069880944 @default.
- W2014302862 cites W2073512707 @default.
- W2014302862 cites W2075577088 @default.
- W2014302862 cites W2077362814 @default.
- W2014302862 cites W2079169944 @default.
- W2014302862 cites W2084343172 @default.
- W2014302862 cites W2086793456 @default.
- W2014302862 cites W2088745874 @default.
- W2014302862 cites W2096806055 @default.
- W2014302862 cites W2098780362 @default.
- W2014302862 cites W2100409734 @default.
- W2014302862 cites W2104099864 @default.
- W2014302862 cites W2117622300 @default.
- W2014302862 cites W2118094322 @default.
- W2014302862 cites W2120235169 @default.
- W2014302862 cites W2121534499 @default.
- W2014302862 cites W2122818027 @default.
- W2014302862 cites W2123493995 @default.
- W2014302862 cites W2125966706 @default.
- W2014302862 cites W2127642431 @default.
- W2014302862 cites W2132715232 @default.
- W2014302862 cites W2133217116 @default.
- W2014302862 cites W2135856179 @default.
- W2014302862 cites W2137177722 @default.
- W2014302862 cites W2140745413 @default.
- W2014302862 cites W2140773214 @default.
- W2014302862 cites W2141386688 @default.
- W2014302862 cites W2142563692 @default.
- W2014302862 cites W2143144750 @default.
- W2014302862 cites W2145632481 @default.
- W2014302862 cites W2146582345 @default.
- W2014302862 cites W2147056242 @default.
- W2014302862 cites W2147273166 @default.
- W2014302862 cites W2148959930 @default.
- W2014302862 cites W2150964163 @default.
- W2014302862 cites W2152094259 @default.
- W2014302862 cites W2152798629 @default.
- W2014302862 cites W2156825907 @default.
- W2014302862 cites W2159334576 @default.
- W2014302862 cites W2166819422 @default.
- W2014302862 cites W2168907840 @default.